MYC-induced cancer cell energy metabolism and therapeutic opportunities. - Wikidata - awgldk - TriplyDB

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

http://www.wikidata.org/entity/Q37438881

about

Cancer as a metabolic disease Stable isotope-resolved metabolomics and applications for drug development Insights into the Regulatory Role of Non-coding RNAs in Cancer Metabolism Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells The Warburg effect and drug resistance Energy metabolism in neurodevelopment and medulloblastoma Interplay Between Metabolism and Oncogenic Process: Role of microRNAs Hypoxia and metabolic adaptation of cancer cells Keap1/Nrf2 pathway in the frontiers of cancer and non-cancer cell metabolism Metabolic reprogramming: the emerging concept and associated therapeutic strategies Oncogenes strike a balance between cellular growth and homeostasis Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies Noncoding RNA in oncogenesis: a new era of identifying key players MYC and the art of microRNA maintenance c-MYC-miRNA circuitry: a central regulator of aggressive B-cell malignancies Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networks Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated metabolic reprogramming P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy MYC activation is a hallmark of cancer initiation and maintenance Mitochondrial structure, function and dynamics are temporally controlled by c-Myc Metabolic maintenance of cell asymmetry following division in activated T lymphocytes Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects Reexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters BET bromodomain inhibition as a therapeutic strategy to target c-Myc Targeting 6-phosphofructo-2-kinase (PFKFB3) as a therapeutic strategy against cancer Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanisms Anoikis resistance: an essential prerequisite for tumor metastasis Phytochemicals attenuating aberrant activation of β-catenin in cancer cells Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells Disruption of Fnip1 reveals a metabolic checkpoint controlling B lymphocyte development

P2860

Q21245061-EEC636A2-6EBB-425F-8709-83648BDDC482 Q24629149-58A55728-741C-4E49-AE1E-7D4A696831BC Q26739857-113EA702-B08A-4635-A3F9-F25182BF9D64 Q26745461-0E826CD3-4C3C-4B4E-8BDA-099A45E32E00 Q26750861-3C827215-AAB1-4ACB-A130-27EEB4F5774F Q26770007-A0E9E607-74F1-4DD9-A9AC-C07F261B6EF0 Q26770345-DE76E4E7-E956-448D-9439-35276DB2191A Q26770381-349F83A2-F755-4075-AE2F-ECC471342CBC Q26774856-FDC47EEA-54E6-431F-A755-D4F7F5A0601F Q26778362-7D33BFB7-3D4A-4BCA-8A06-0DFC94A74BE4 Q26786595-FCD49BF1-21F3-4F58-A23E-198E96AD7B6E Q26798085-7E7C1872-3595-4262-A117-C7A79F263D67 Q26823118-5C5611B7-A101-4381-B168-F50B4120390C Q26823718-570E2FDD-6449-4754-BADA-A24C10193D33 Q26825457-3EA3E614-3D21-4794-B73B-FFB5F3E0B4E9 Q26851373-0591400E-D258-40EA-BC3E-32FD7B92F5BE Q26851585-2E39ED56-109A-4C76-B028-FA5E3D33757D Q26852398-65308F3A-E1B3-4235-8D7C-B3BA0BBA1D1F Q26853482-AB3EB906-A50B-4909-91EA-B10663394A42 Q26853567-B8C78AF7-60C7-413C-A4F0-CFE299713165 Q26991931-BAF76BF0-44F0-4227-8EC5-36D06EB1C663 Q27011547-443A93D3-B445-46A3-95F3-4A7C37751E04 Q27026026-309F1C5C-740F-4ECB-8E6A-74309D6FFFEA Q27302245-DBBB79DF-F5A3-46C5-B3BA-E6D4794FA78A Q27314597-02267CFD-FD95-4C29-A8AF-E5F646F808BB Q28073524-22AD8C38-9011-4584-8F65-65C01F9661F1 Q28076454-A4C04A3F-F3EF-4987-BECF-5464B16B836A Q28077883-6EF8752F-80BB-4C73-B4FC-4D64514C71C5 Q28078259-D24DCDC7-0E0F-40AC-AFA5-3BAA1BBF7901 Q28081811-93EA641D-0376-494D-9DE9-823B9C16944C Q28247024-0C8A2A3C-6201-4031-ACB5-73E9C050CCD6 Q28290629-FEB56705-25C1-412F-B1BF-55DB812E2880 Q28297381-F9F46726-D4F6-446D-B317-19DDAB5F2919 Q28385000-0A38B28D-2F47-4909-BB5E-74B514CFADEE Q28387168-689B0401-CBD3-4EBA-82A4-2F371DA58E77 Q28392625-3C421F26-C6D7-4EB9-8B8A-A062623E0691 Q28397372-ADAC543E-B021-4CD1-8E4D-7BFA088A5AAB Q28485445-C3E37218-4F12-4ABB-BA18-0E8E24887D6D Q28504783-9F746FD6-1B94-4470-BD1F-42A726B3A826 Q28507620-8C0F12D9-D137-4F61-BCFC-4E04172297F7

P2860

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

http://www.wikidata.org/entity/Q37438881

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

@en

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

@nl

type

label

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

@en

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

@nl

prefLabel

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

@en

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

@nl

P1433

Q37438881-E128CF6B-BD70-4961-9997-A6FA21C52CC2

P1476

Q37438881-1759478E-D638-4A27-8439-905FCE88D9DE

P2093

Q37438881-A68F4E46-B1CC-460D-8A4F-BB40CCAFD684

P2860

Q37438881-058A6244-11A9-4127-BCCF-867370A6FE89

Q37438881-0F49A9CE-E4ED-4EFC-BCDC-48C32D3A0561

Q37438881-1674BE31-C151-4CF4-8D1C-8898B0F0F05E

Q37438881-1934DA39-B482-480D-8DB7-3E4622271B1B

Q37438881-19467D7B-03FC-4EEA-940B-DE2FF06A5B85

Q37438881-1EAA7AE8-301E-4217-A6BA-7A1946F2298C

Q37438881-2150BBE9-052C-463D-BE1F-72944D4FCAB6

Q37438881-2314969C-BEE6-49AF-8762-59F2107D8C33

Q37438881-279ACC7F-090D-45DC-B876-FBC05D075970

Q37438881-2F00352B-E4C2-471C-8763-F4C8A8B5E8A5

P304

Q37438881-74C3E4DB-5981-42D9-A606-6C6F66B8C4C1

P31

Q37438881-E08962C8-4118-4938-ACE3-FD76097D1DD3

P356

Q37438881-24A92C9E-2143-4A36-B45B-EEB52AE76F05

P407

Q37438881-0297B7CC-9913-4BBD-821D-B45C308F2FF1

P433

Q37438881-CD52A8AE-A6B6-41E2-861A-912A337B4322

P478

Q37438881-37F93EAB-3D5D-4037-8959-C49E240E81AD

P50

Q37438881-AE016B9F-BD44-4B8C-9C9C-6482E5BF0F69

Q37438881-D6B32299-FFB6-4C9D-8551-D592C36F4184

P577

Q37438881-E016DF02-7F23-4320-8F1F-F7D487D5B83E

P698

Q37438881-215718A1-75DD-4F6E-A643-8EFCC702C1BF

P932

Q37438881-B92839A8-6897-45DE-BA1F-6FB6DF5C4553

P356

1078-0432.CCR-09-0889

P1433

Clinical Cancer Research

P1476

MYC-induced cancer cell energy metabolism and therapeutic opportunities.

@en

P2093

Ping Gao

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene

Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Hexokinase-2 bound to mitochondria: cancer's stygian link to the "Warburg Effect" and a pivotal target for effective therapy

miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression

Brick by brick: metabolism and tumor cell growth

Genomic targets of the human c-Myc protein

Global mapping of c-Myc binding sites and target gene networks in human B cells

Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1

Pyruvate kinase M2 is a phosphotyrosine-binding protein

P304

6479-6483

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-0889

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19861459

http://www.w3.org/2001/XMLSchema#string

P932

2783410

http://www.w3.org/2001/XMLSchema#string